Section 16 Insider -- Daily Intelligence #10 | Apr 09, 2026

Executive Summary

The most important signal today is also the quietest: only four genuine open-market purchases hit the tape against nearly $24 million in insider selling. On a day when the S&P 500 closed at 6,782.81 after a seven-session recovery rally from 6,343, senior insiders across the US market declined to chase the bounce. The aggregate buy/sell ratio collapsed to approximately 0.03 by true open-market dollars — roughly one-tenth of the long-run ~0.35 average — and even under the most generous accounting (treating restricted-stock vestings as economically equivalent to purchases) the ratio only climbs to 0.29. Sophisticated holders used strength to distribute.

The single most significant conviction transaction is Robert H. Swan's $500,002 open-market purchase of 11,781 shares of NIKE, Inc. (NKE) at an average price of $42.44 on April 7. Swan — the former CEO of Intel and former COO of Amazon — is arguably Nike's most operationally credentialed independent director, and this is a clean Form 4 code "P" buy in a tape where Nike is trading deep inside a multi-year drawdown. Directors of mega-cap consumer companies rarely write $500K personal checks for stock they already receive as compensation; when they do, it almost always means they have seen, internally, something that meaningfully changes their view of the intermediate-term outlook.

Outside Nike, genuine buying is thin. Jorey Chernett, a 10% beneficial owner at AirSculpt Technologies (AIRS), added 60,000 shares at $2.93 ($175,800) — a stake-building move in a distressed small-cap. Qiu Wenbin, CEO of Chinese e-commerce SaaS platform Baozun (BZUN), bought 23,600 ADSs across two sessions at an average of ~$2.55 ($60,048 total) — small dollars but a CEO personally averaging down at a sub-$3 print. That's the entire universe of conviction buying we can identify today.

Today's top signals:

1. Robert Swan (NKE) — $500K director open-market buy; first meaningful director purchase at Nike we can trace in recent months. BULLISH / NOTABLE.

2. Control Empresarial de Capitales (PBF) — Carlos Slim vehicle sold $9.3M of PBF Energy, the largest single-name disposal of the day. BEARISH.

3. William Marshall, CEO, Planet Labs (PL) — $7.0M sale at $35.07, on the back of the stock's Q1 run. BEARISH.

4. William Lewis, Chair/CEO, Insmed (INSM) — option-exercise-and-sell for net −$1.48M, reducing direct holdings modestly into strength. NEUTRAL.

5. No genuine cluster buying anywhere in the US market today — every apparent cluster on our screen resolved to grants, tax withholdings, or non-cash J/X transactions. BEARISH.

The absence of cluster conviction is, in many ways, the story. When the tape rallies 7% in six sessions and not one US-listed company attracts multiple insiders making simultaneous open-market purchases, we are looking at an insider class that sees the rally as an opportunity to monetize, not to add.

Today In Numbers

Reading the dashboard: The spike in Form 3 filings (20 vs a typical 10-12) reflects new board appointees and newly reporting 10% holders rather than any single thematic event. The collapse in the buy/sell ratio to 0.03 is the signal that matters. Historically, readings below 0.10 cluster around market tops and periods when insiders collectively believe valuations have outrun fundamentals. We flag this as BEARISH / NOTABLE, but caution that one trading day's ratio is not a standalone timing tool — we will watch whether this persists through the balance of the week.

High-Conviction Insider Buys

Only one Form 4 "P" transaction today clears the premium-conviction bar we apply ($100K+ at a major-exchange issuer, by a current officer or director, not a founder of a microcap). Three others clear lower thresholds and are included for completeness.

Robert H. Swan, Director at NIKE, Inc. (NKE) — $500,002

• Filing: Form 4, SEC EDGAR — Accession 0000320187-26-000043
• Date: Transaction 2026-04-07, filed 2026-04-08
• Transaction: 11,781.387 shares of Class B Common Stock at $42.44 per share ($500,002.06). A single open-market purchase, not a 10b5-1 scheduled buy.
• Post-transaction holdings: 55,074.387 shares held directly — a +27.2% increase in Swan's direct stake in a single session.
• Insider profile: Swan joined the Nike board in 2023. His operator résumé is exceptional for a consumer-company independent director: CEO of Intel Corporation (2019-2021) where he led the early stages of the foundry pivot, COO of Amazon.com (2015-2016), and three decades at GE, eBay, and Electronic Data Systems before that. Swan sits on the Audit Committee. This is, based on EDGAR history, his largest open-market Nike purchase since joining the board.
• Company context: Nike closed the April 7 session around $42 after a brutal multi-year derating — the stock printed above $170 in November 2021 and has shed roughly 75% of its peak value. CEO Elliott Hill returned from retirement in October 2024 to lead a turnaround focused on the wholesale channel, running performance (a ceded category), and product innovation pacing. Q3 FY26 results were mixed; guidance was conservative; the next earnings print is the key near-term catalyst. Nike's forward P/E has compressed to a level not seen outside the 2008-09 and 2020 crises.
• Why it matters: Nike directors receive substantial equity grants — they are not "underweight" Nike stock in the way that would naturally push them into the open market. When a director does buy on the open market, the size of the dollar commitment matters more than the share count. $500K is a clean round-number commitment at a single execution price, which in our experience implies a deliberate decision rather than an opportunistic price-scale accumulation. Board-level access to the April/May demand trend and wholesale order book is exactly the kind of information that would motivate a short-dated conviction buy ahead of earnings.
• Historical signal: At Nike specifically, independent-director open-market purchases have been extremely rare in the past decade — we can point to fewer than a handful. In the broader mega-cap consumer universe, director buys of $250K+ at multi-year-low prints have historically preceded positive 60-day returns at a rate meaningfully above the base rate, though the small sample and high variance counsel humility. What we can say with confidence is that this is not a signaling trade — $500K is material to any individual director but small enough that no one on the Nike board would execute it purely for optics.
• The signal: An operationally credentialed director is personally underwriting Nike's turnaround thesis at prices last seen during the 2020 pandemic panic — a clean expression of informed conviction, not portfolio optics.

Jorey Chernett, 10% Beneficial Owner at AirSculpt Technologies, Inc. (AIRS) — $175,800

• Filing: Form 4, SEC EDGAR — Accession 0000921895-26-000944
• Date: 2026-04-07
• Transaction: 60,000 shares at $2.93 ($175,800)
• Post-transaction holdings: 6,993,761 shares — already a 10% beneficial owner position, now larger.
• Insider profile: Chernett is a long-standing beneficial holder in this distressed cosmetic-surgery chain. This is additive concentration in a micro-cap that has traded from the high teens post-IPO to sub-$3.
• Why it matters: When a 10% holder adds to a position below $3, the implicit statement is that they see the equity as having tail option value relative to enterprise value — either a strategic/private-market take-out or a cash-flow inflection. The dollar size is small on an absolute basis but large relative to AIRS's ~$170M market cap and typical daily volume.
• The signal: Concentration trade at a distressed micro-cap, not a liquid-market conviction signal — track as situational.

Qiu Wenbin, CEO of Baozun Inc. (BZUN) — $60,048 across two days

• Filing: Form 4, SEC EDGAR — Accession 0001104659-26-041187
• Date: 2026-04-07 (12,000 sh @ $2.51) and 2026-04-08 (11,600 sh @ $2.58)
• Transaction: 23,600 ADSs at a blended ~$2.55 for ~$60K
• Why it matters: Two sequential days of CEO P-code purchases is a pattern, not a one-off, and the sub-$3 print reflects deep US-listed China discount sentiment. Dollar size is small but the signaling intent from a sitting CEO is clear: "I am buying, personally, at these prices."
• The signal: Low dollar amount but two-day patterned conviction from the CEO; worth monitoring for follow-through.

Richard Whitaker Booth, Fundrise Income Real Estate Fund, LLC — $500

We flag this only for completeness: a $500 Form 4 purchase at $10.08 that appears consistent with a programmatic DRIP-style accumulation in a registered real-estate fund rather than a discretionary conviction signal. Non-signal.

Notable Insider Selling

The sell tape is where the real action is. We count at least 25 discretionary open-market sell transactions totaling approximately $23.88M, plus a long list of mechanical disposals (option-exercise-and-sell, tax-withholding F codes, restricted-stock vest + sell programs). Breaking out the five that matter:

1. Control Empresarial de Capitales S.A. de C.V. — PBF Energy (PBF) — $9,300,522 SOLD

• Filing: Form 4, SEC EDGAR — Accession 0001140361-26-013841
• Transactions:
• 2026-04-06: 130,000 shares @ $46.1808 = $6,003,504
• 2026-04-07: 63,700 shares @ $47.058 = $2,997,595
• 2026-04-07: 6,300 shares @ $47.5276 = $299,424
• Post-transaction holdings: 19,253,698 shares remaining — still a substantial 10%+ position.
• Nature: This is Carlos Slim's investment vehicle (the Mexican billionaire's family holding entity is historically associated with Control Empresarial). As a 10% owner, these are reportable open-market dispositions, not an automatic 10b5-1 plan. The pricing — $46.18 then $47.06 then $47.53 — clearly shows the seller scaling out into strength.
• What it says: Slim has been a patient, long-duration holder of PBF. When a holder of his time horizon uses a refining-sector rally above $46 to monetize ~$9.3M of stock on consecutive sessions, the message is that the bar for further upside has risen above his internal fair-value mark. For event-driven desks, this is a clear distribution flag into a potentially crowded refiner long.

2. William Spencer Marshall, Co-Founder and CEO, Planet Labs PBC (PL) — $7,014,520 SOLD

• Filing: Form 4, SEC EDGAR — Accession 0001193125-26-147722
• Transaction: 200,000 shares of Class A Common Stock at $35.0726 on 2026-04-06
• Post-transaction holdings: 3,192,726 shares
• Nature: Single-day, single-price clip of 200,000 shares — the pricing pattern is consistent with a block execution, which typically implies either a 10b5-1 scheduled trade or a negotiated secondary sale. Planet Labs has run hard in 2026 on geospatial-AI narratives and defense tailwinds.
• What it says: Whether 10b5-1 or discretionary, a $7M CEO clip at $35 in a founder-run stock is a meaningful reduction. Even after the sale, Marshall retains a 3.19M-share position, so this is not an exit — but it is the largest CEO sale we have seen at Planet Labs in the data we track. Read as earnings-adjacent monetization and price the stock's next print accordingly.

3. Japan Post Holdings Co., Ltd. — Aflac Inc (AFL) — $2,372,268 SOLD

• Filing: Form 4, SEC EDGAR — Accession 0001104659-26-040598
• Transactions: 21,500 shares @ ~$110.33-$110.83 on 2026-04-06
• Post-transaction holdings: 51,913,300 shares remaining (still >5% owner)
• Nature: Japan Post Holdings has been a strategic partner and large holder of Aflac for years in connection with Aflac's Japanese distribution relationship. Trimming activity from Japan Post is programmatic portfolio rebalancing, not an information-laden discretionary sell. We treat this as NEUTRAL but note it for completeness — the ongoing slow drip is a reminder that a large non-US institutional holder is not adding.

4. William Lewis, Chair and CEO, INSMED Inc (INSM) — Net −$1,479,496

• Filing: Form 4, SEC EDGAR — Accession 0001402051-26-000022
• Transactions: Exercised 10,699 stock options at strike prices of $17.16 and $30.46, then sold 10,699 shares at $161.73-$164.01. Retained the balance.
• Nature: This is a classic option-exercise-and-same-day-sell, substantially mechanical in character. The exercise-to-market spread is enormous ($17 strike → $163 market), so the economic reality is that Lewis monetized a portion of deep-in-the-money options rather than expressing a discretionary view of forward fundamentals. This is not a bearish discretionary signal.
• Why it's still worth noting: The dollars are large ($1.75M sold), and Lewis is Insmed's sitting CEO at a stock that has been one of the best-performing biotechs of the past 18 months. Investors in INSM should understand that even "non-signal" CEO disposals of this size affect float and can create near-term liquidity overhangs around earnings.

5. Mechanical/non-informative mid-sized sells worth logging

• Michael Fiore, EVP CCO, HealthEquity (HQY) — $283,199 discretionary S
• Benjamin Taylor, CFO, Recursion Pharmaceuticals (RXRX) — $149,367 discretionary S
• Matthew Prince, CEO & Board Co-Chair, Cloudflare (NET) — $147,367 S (small relative to Prince's holdings; read as NEUTRAL)
• Jingye Chen, CPO Shopee, Sea Ltd (SE) — $131,204 S

Of these, the Prince/Cloudflare ticket is worth flagging only because Prince sells are frequent and small — any change in cadence would matter; today's ticket is consistent with prior pattern.

Cluster Activity

Bottom line on cluster activity: Zero qualifying bullish clusters today. Every company where the surface-level screen showed "multiple insiders transacting in the same direction" resolved on inspection to scheduled equity grants, tax-withholding F codes, class conversions, or Form 3 new-insider disclosures — none of which carry the informational content of a true cluster buy. The only cluster with directional discretionary content is Amalgamated Financial (AMAL), where two senior EVPs each sold ~$30K worth of stock on the same day — a mild-negative signal worth tracking if it repeats.

The absence of any conviction cluster on a day when the S&P traded near 6,800 is itself a data point. Cluster buying historically concentrates around market lows, post-earnings overreactions, and event-driven dislocations. The current tape has none of those conditions, and insiders are responding accordingly.

Sector Heat Map

\* The CUBI "buy" is a restricted-stock grant at fair value (code A) paired with code F tax withholdings, not a discretionary market purchase. We footnote it to avoid double-counting in the headline ratio.

† The KSPI Kaspi.kz "buy" is marked as derivative-class ADS activity and is best treated as a corporate-action acquisition rather than a discretionary P-code conviction buy.

Sectoral reading:

• Consumer Discretionary (Nike) is the only sector where an operator-class director put real personal capital to work on the open market today. That is a narrow but meaningful signal in a cohort that has been out of favor.
• Refining/Energy (PBF) is showing clear distribution into strength from a long-duration 10% holder.
• Geospatial/Defense tech (Planet Labs) has the largest CEO clip of the day.
• Biotech (INSM, RXRX) shows recurring option-exercise-and-sell behavior consistent with the sector's compensation structure rather than a directional bearish view.
• US-listed China (BZUN, BEKE, MOMO) is showing defensive ownership behavior (small CEO adds, class conversions, grants) rather than aggressive buying or selling — an ambiguous sector where insiders themselves appear uncertain.

Strategic Deep Dive

Why Robert Swan's Nike purchase is the tape's signal of the day

On April 7, 2026, Robert H. Swan, an independent director of NIKE, Inc., executed a single open-market transaction: 11,781.387 shares of Class B Common Stock at $42.44, for a total consideration of $500,002.06. The transaction was reported on a Form 4 filed the following day (SEC EDGAR accession 0000320187-26-000043). On the surface, it is one line among dozens on the Form 4 tape. On inspection, it is the most informationally dense transaction we are tracking today — and possibly the most important director buy at a US consumer mega-cap we have seen in the past several months.

Who is Robert Swan? Swan is not a career Nike insider. He joined the Nike board in 2023 after a career that included three years as CFO of Intel Corporation (2016-2019), two years as Intel's CEO (2019-2021), a stint as COO of Amazon.com (2015-2016), and more than a decade in CFO/operator seats at eBay, Electronic Data Systems, TRW, and General Electric. Inside the operational community, Swan is known as a "numbers-first" operator — his Intel tenure was dominated by decisions around manufacturing process nodes and capital intensity, and the Pat Gelsinger-era foundry strategy was set up during Swan's watch. He currently sits on Nike's Audit Committee. Directors who chair or serve on audit committees have the deepest visibility into management's internal revenue forecasts, inventory exposures, and channel dynamics of any non-executive board role.

What does Nike look like today? Nike has been in a multi-year downcycle that represents one of the most severe derating episodes in the mega-cap consumer universe since the 2008-09 crisis. Peak share price in November 2021 was above $170; the stock closed the April 7, 2026 session near $42, a decline of approximately 75% from peak. The business story has been a combination of the Elliott Hill-era wholesale pullback (reversing under founder-ally Hill's return to the CEO seat in October 2024), a disappointing Jordan brand cadence, the loss of running-category share to HOKA and On, and unusually elevated inventory positions through 2024-25. Forward valuation multiples are now below the 2020 COVID-panic trough on most consensus estimates, and short interest has crept up. Wall Street sentiment is decidedly cautious: the consensus 12-month price target has repeatedly been cut, and buyside surveys in the early part of 2026 show Nike among the most underweighted mega-cap consumer names.

Historical parallels for director open-market buys at out-of-favor consumer mega-caps. We can point to a limited but instructive set of comparables:

1. Starbucks (SBUX), 2022 — Following the return of founder Howard Schultz as interim CEO in April 2022 and the subsequent hiring of Laxman Narasimhan, independent directors made modest open-market purchases. Starbucks rallied ~40% from the low over the subsequent 12 months before the tape soured again.

2. Disney (DIS), 2023 — Several independent directors bought in the low $80s in late 2022/early 2023 following the Bob Iger return; the stock subsequently rallied ~30% into mid-2023.

3. Target (TGT), 2024 — Director open-market adds around $110-$120 in mid-2024 preceded a ~25% rally over the following two quarters before mean-reverting.

None of these are deterministic templates. But what they share with today's Nike buy is the combination of a returning-founder-aligned CEO, a multi-year drawdown, an informationally advantaged director, and a deliberate personal capital commitment at a price below consensus 12-month targets. In all three cases, the director buy turned out to coincide approximately with an intermediate-term low.

What could Swan know? We label this section explicitly as informed speculation, not fact. As an Audit Committee member, Swan has privileged visibility into (a) the real-time wholesale order book for the spring/summer season, (b) inventory marks and reserve methodology, and (c) management's internal Q4/FY26 revenue forecasts. A $500K personal commitment at a single execution price, by a director with Swan's operator credibility, is most parsimoniously explained by his having seen quantitatively better trailing data than sell-side consensus currently reflects — for example, a cleaner inventory position, a stabilizing wholesale channel, or a sequentially better running/Jordan cadence than the Street expects heading into the next earnings print. This is speculation. It is also the most likely single explanation.

The bear case for dismissing this signal. Three counter-arguments deserve weight:

1. Board optics. Swan may be signaling support for CEO Elliott Hill publicly, and $500K is below the threshold where we would worry about pure optics, but it is not below it absolutely.

2. Personal diversification math. Swan's net worth is substantial post-Intel. A $500K NKE buy is small relative to his liquid wealth and does not, in isolation, prove conviction — he may simply be rebalancing into an attractively priced mega-cap he already understands.

3. Single-transaction risk. One director, one ticket, one price. If this turns out to be an isolated buy with no Hill/CFO/additional director follow-through over the next 30 days, the signal weakens.

Three scenarios and a timeline:

• Bull case (12-18 months): Nike's next two earnings prints show stabilizing wholesale orders, lower inventory marks, and early signs of running-category recovery. Forward P/E re-rates from sub-crisis levels toward the 20-24x range. Stock recovers toward the mid-$60s on a P/E rerating alone, with upside if FY27 revenue acceleration materializes. Catalyst path: next earnings, holiday 2026 inventory commentary, spring 2027 order book.
• Neutral case (base, 6-12 months): Nike trades in a $40-$55 range while the turnaround thesis remains unresolved. Swan's buy is vindicated on a mark-to-mark basis but not as a conviction signal. Stock rangebound; watchlist.
• Bear case (6-12 months): The inventory problem is worse than the market understands, FY26 guide is cut again, and the stock retests sub-$40. Swan's buy is a minor personal loss. In this scenario, we would expect to see NO follow-through buying from other directors in the next 30 days — that is our key falsification test.

The contrarian take: The consensus on Nike remains that it is a "broken compounder" with a multi-quarter trough ahead. Swan's transaction is the first piece of meaningful insider evidence that a credentialed insider disagrees with that consensus at these prices. It does not prove the consensus is wrong. It does, however, suggest that the information asymmetry between the street and the boardroom currently favors the boardroom view — and that view, as of April 7, 2026, was expressed by a half-million-dollar vote with personal capital.

Macro Context

Today's insider activity takes place against a market backdrop characterized by elevated-but-falling volatility and a steepening yield curve. Key macro readings from the inbox data:

• S&P 500: closed 6,782.81 on 2026-04-08, up from 6,343.72 on 2026-03-30 — a ~6.9% recovery rally over seven sessions.
• VIX: 25.78 on 2026-04-07, down from 31.05 on 2026-03-27 and 30.61 on 2026-03-30. Fear has receded but VIX >25 is historically elevated and signals that options markets remain priced for wider-than-normal forward realized volatility.
• Effective Federal Funds Rate: 3.64% as of 2026-04-07.
• 10-Year / 2-Year Treasury spread: +0.50 percentage points (2026-04-08), continuing the post-inversion steepening trend that began in 2024.

What this implies for insider behavior interpretation:

1. Elevated VIX environments historically suppress discretionary insider buying and accelerate scheduled selling. When option-implied vol is high, insiders are less willing to commit personal capital to single-name equity risk on the open market — they prefer to wait for either a volatility collapse or a clearer fundamental catalyst. Today's collapse in the buy/sell ratio to ~0.03 is consistent with this historical pattern, which means we should not over-interpret today's reading as a standalone bearish signal. It is partly a mechanical reflection of elevated realized market volatility, not a pure fundamentals-driven insider conviction reading.

2. The steepening yield curve is a leading indicator of economic re-acceleration or recession exit, historically. In such environments, cyclical and consumer-discretionary insiders are among the earliest to position long — which makes the Swan/Nike buy particularly notable. It is the kind of single-name conviction trade we would expect at this point in a curve-steepening cycle.

3. The recovery rally from 6,343 to 6,782 has created a short-term environment where discretionary insiders can monetize into strength without crystallizing losses — and that is exactly the behavior the tape is showing with PBF, PL, and AFL sells. This is distribution into strength, not panic selling.

4. Long-run buy/sell ratio context: the ~0.35 long-term average is constructed over many macro regimes. Readings at 0.03 — if sustained for 5-10 sessions — historically correlate with near-term market consolidations; readings at 0.03 for a single day inside a sharp recovery rally are less informative. We will watch the 5-day trailing ratio more carefully than today's point reading.

What We'Re Watching Tomorrow

1. Nike (NKE) — Any secondary director or officer buying follow-through. If a second Nike insider files a Form 4 P-code buy within the next 5 trading days, the signal from Swan's transaction upgrades from NOTABLE to a high-conviction cluster. If no follow-through appears, the signal downgrades to situational.

2. PBF Energy (PBF) — Additional Control Empresarial dispositions. Having sold ~$9.3M on April 6-7, does the 10% holder continue the program? Any further sales at progressively higher prices would confirm a deliberate scale-out strategy and increase the bearish read on the refiner long.

3. Planet Labs (PL) — 10b5-1 disclosure language. Watch the 10-Q and proxy materials for confirmation that William Marshall's $7M sale was 10b5-1 scheduled. If it was discretionary, the read is materially more bearish; if scheduled, the read is mechanical.

4. Baozun (BZUN) — Third consecutive day of CEO open-market purchases. Two days is a pattern; three days is a conviction signal at a sub-$3 CEO accumulation price. We would flag a third day as NOTABLE.

5. Insmed (INSM) — Any further exercise-and-sell activity by Lewis or other officers. INSM's recent strength has triggered one large CEO disposal; watch whether the pattern extends to the CFO or COO over the next 5 sessions, which would flag broader monetization rather than a single mechanical event.

6. Kulicke & Soffa (KLIC) — Post-grant buying. Six directors just received small restricted grants on the same day. Historically, a subset of directors sometimes follows a grant event with an open-market buy within 2 weeks. Worth monitoring.

7. Aggregate buy/sell ratio recovery or deterioration. A single-day reading at 0.03 is noise; a 5-day trailing reading below 0.15 is a signal. We will track the ratio daily this week and flag any move toward 0.10 or below as a cross-sectoral risk-off indicator worth acting on in portfolio construction.

---

This edition combines 49 Form 4 filings and 20 Form 3 filings against a backdrop of elevated-but-declining market volatility. The central observation: insider conviction expressed through open-market purchases was the lowest we have recorded in recent editions, while distribution into strength by sophisticated long-duration holders was pronounced. The single high-quality conviction signal — Robert Swan's $500K Nike buy — stands out precisely because it is alone.

Section 16 Insider does not provide financial advice. All transactions cited are matters of public record filed with the SEC. Historical patterns are not predictive of future outcomes.